What is Immunotherapy? | Bladder Cancer Canada

Understand how immunotherapy works to fight bladder cancer in this expert-led webinar with Dr. Aly-Khan A. Lalani. Learn about treatment options, benefits, and side-effect management for advanced, metastatic, and post-surgery patients. This educational session covers: How immunotherapy primes the immune system to attack cancer cells Key treatments like PD-1 / PD-L1 inhibitors (pembrolizumab, nivolumab) and CTLA-4 inhibitors Use in advanced/metastatic bladder cancer and post-surgery (adjuvant) settings Evidence from clinical trials such as KEYNOTE-045 and JAVELIN Bladder 100 Managing immune-related side effects with monitoring and medications Future directions, including research in earlier-stage disease and combination therapies Watch now to better understand immunotherapy and how it may fit into bladder cancer care. Edited by: Osman Force. Read more on our website: What is Immunotherapy? | Bladder Cancer Canada (https://bladdercancercanada.org/en/wh...)